Allergen Immunotherapy

알레르기 질환에서의 면역치료

Park, Hae-Sim
박해심

  • Published : 20020000

Abstract

Keywords

References

  1. Peter SC. The consideration of immunotherapy in the treatment of allergic asthma. Ann Allergy Asthma Immunol 87:13-2 7, 2001. https://doi.org/10.1016/S1081-1206(10)62190-4
  2. F Purello-D'ambrosio, S Gangemi, RA Merendino, S Isola, P Puccinelli, S Parmiani et al. Prevention of new sensitizations in monosensitiz ed subjects submitted to specific immunotherapy or not. A2001.
  3. Bonifazi F, Bilo MB. Efficacy of specific immunotherapy in allergic asthma: myth or reality ? Allergy 52:698- 710, 1997.
  4. Thomas AE Platts-Mills, Geoffrey AM, Lisa MW. Future directions for allerg en immunotherapy. J A llergy Clin Immunol 102: 335-43, 1998. https://doi.org/10.1016/S0091-6749(98)70117-4
  5. European academy of allergy and clinical immunology: Immunotherapy position paper. Allergy 43:7-33, 1988.
  6. WHO/ IUIS working group report : Current status of allergen immunotherapy. Lancet 4: 259- 61, 1989.
  7. BSACI Symposium on specific allergy '96. Clin Exp Allergy 26:980-5, 1996. https://doi.org/10.1111/j.1365-2222.1996.tb00636.x
  8. 조상헌. 한국의 면역치료 현황 및 지침. 알레르기 15:390-5, 1995.
  9. 대한 천식 및 알레르기 학회: 한국의 기관지천식 치료 지침. 면역요법. 천식 및 알레르기.
  10. 대한 천식 및 알레르기 학회: 한국의 알레르기비염 진단과 치료 지침서. 천식 및 알레르기 19:837-69, 1999.
  11. Park HS, Oh SH, Hong CS. The comparison of allergic responses to Dermatop hagoides farinae between bronchial asthma and allergic rhinitis. Ann Allergy 63:399-404, 1989.
  12. David BKG: S ting insect vaccines. Immuno Allergy Clin N orth A m 20:553- 70, 2000. https://doi.org/10.1016/S0889-8561(05)70166-1
  13. 안성균, 김선신, 김희연, 남동호, 박해심: 벌독 아나필락 시스 환자의 임상적 특성. 천식 및 알레르기 19:492 - 7, 1999.
  14. Kim SS, Park HS, Kim HY, Lee SK, Nahm DH. A nap hylaxis caused by the new ant, Pachycondyla chinensis: Demonstration of specific IgE and IgE - binding components. J Allergy Clin Immuno 107:1095- 9, 2001. https://doi.org/10.1067/mai.2001.114341
  15. Kim YK, Son JW, Kim HY, Park HS, Lee MH, Cho SH et al. N ew occupational allergen in citrus farmers: citrus red mite(Panonychuscitri). Ann Allergy Asthma Immunol 82:223-8, 1999. https://doi.org/10.1016/S1081-1206(10)62601-4
  16. Kim YK, Son JW, Kim HY, Park HS, Lee MH, Min KU et al. Citrus red mite (Panony chus citri) is the most common sensitizing allergen in subjects with asthma and allergic rhinitis in citrus farmers in Korea. Clin Exp Allergy 29:1102 -9, 1999. https://doi.org/10.1046/j.1365-2222.1999.00607.x
  17. Jee YK, Park HS, Kim YK, Park JK, Lee KY, Kim KY et al. Two- spotted spider mite (Tetrany chu urticae) is an important allergen among asthmatic non-farmers whose symptoms were aggravated in summer and early fall season. Ann Allergy Ashtma Immunol 84:543, 2000.
  18. Kim HY, Park HS, Kim YK, Son JW, Kim HA, Suh JH et al. Identification of IgE - binding components of citrus red mite in sera of patients with citrus red mite- induced asthma. J A llergy Clin Immuno 107:244-8, 2001. https://doi.org/10.1067/mai.2001.112123
  19. Park HS, Nahm DH, Suh CH, Lee SM, Choi SY, Lee SY et al. Evidence of H op Japanese p ollinosis in Korea: IgE sensitization and identification of allergenic components. J Allergy Clin Immunol 100:475-9, 1997. https://doi.org/10.1016/S0091-6749(97)70138-6
  20. Park HS, Nahm DH, Kim HY, Suh YJ, Cho JW, Kim SS et al. Clinical and immunologic changes after allergen immunotherapy with H op Japanese pollen. Ann Allergy Asthma Immuno 86:444-8, 2001. https://doi.org/10.1016/S1081-1206(10)62493-3
  21. 권순석. 알레르기 질환에서의 DNA vaccine. 천식 및 알레르기 20:567- 76, 2000.
  22. 송만기, 성영철, 이창우. DNA를 이용한 백신 및 치료. 천식 및 알레르기 21:155- 60, 2001.
  23. James SW, Sanjiv S. CpG oligonucleotide modulation of allergic inflammation. A llergy 56: 365- 76, 2001.
  24. Shyam SM, Homero SJ. N ovel immunotherapeutic app roaches f or the treatment of allergic diseases. Immuno A llergy Clin North A m 20:625-42, 2000. https://doi.org/10.1016/S0889-8561(05)70170-3
  25. Shannon AB, Brian J O'Connor, Salah M, Margaret JL, Varsha K, Jamey K et al. Effect of recombinant human interleukin- 12 on eosinophils, airway hyperresp onsiveness, and the late asthmatic response. Lancet 356:2149-53, 2000. https://doi.org/10.1016/S0140-6736(00)03497-8
  26. Milgrom H, Fick RB, Su JQ et al. Treatment of allergic asthma with monclonal anti- IgE antibody. N Eng l J M ed 341:1966- 73, 1999. https://doi.org/10.1056/NEJM199912233412603
  27. Boulet LP, Chapman KR, Côte J et al. Inhibitory eff ects of anti- IgE antibody E25 on allergon- induced early asthmatic resp onse. Am J R esp Crit Care Med 155: 1835-40, 1997. https://doi.org/10.1164/ajrccm.155.6.9196083
  28. Larry CB, Harold SN, Miguel JL, Lori C, James BW, Jan MA et al. Interleukin-4 recep tor in moderate atopic asthma. Am J R esp ir Crit Care Med 160:1816-23, 1999. https://doi.org/10.1164/ajrccm.160.6.9808146
  29. Margaret JL, Anneke ten B, Jamey K, Zuzana D, Brian J O'Connor, Christine MW et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2144-8, 2000. https://doi.org/10.1016/S0140-6736(00)03496-6